More distantly, about 20 HIV vaccines are currently in clinical trials, according to the New York-based AIDS Vaccine Initiative (IAVI).

FORBES: Magazine Article

Another 60 antivirals have begun clinical trials, aimed primarily at HIV, the virus that can lead to AIDS, and hepatitis B and C.

FORBES: The Golden Age of Antiviral Drugs